Intuitive Surgical (ISRG) Receives Daily News Sentiment Rating of 0.20
Media coverage about Intuitive Surgical (NASDAQ:ISRG) has trended somewhat positive on Thursday, according to Accern. The research firm identifies positive and negative news coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Intuitive Surgical earned a news sentiment score of 0.20 on Accern’s scale. Accern also assigned news stories about the medical equipment provider an impact score of 46.1658030853859 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.
These are some of the media headlines that may have effected Accern’s scoring:
- Zacks: Brokerages Anticipate Intuitive Surgical, Inc. (ISRG) Will Post Earnings of $1.99 Per Share (americanbankingnews.com)
- Is Intuitive Surgical, Inc. a Buy? – Motley Fool (fool.com)
- Intuitive Surgical (ISRG) Lifted to Buy at Zacks Investment Research (americanbankingnews.com)
- Technical Snapshots for Investors – Intuitive Surgical Inc (NASDAQ: ISRG) – Alpha Beta Stock (alphabetastock.com)
- Intuitive Surgical (ISRG) Upgraded to “Strong-Buy” at Vetr (americanbankingnews.com)
A number of brokerages recently commented on ISRG. Citigroup reaffirmed a “buy” rating and set a $531.00 price target on shares of Intuitive Surgical in a research report on Friday, January 26th. Stifel Nicolaus reaffirmed a “buy” rating and set a $480.00 price target (up from $400.00) on shares of Intuitive Surgical in a research report on Thursday, January 25th. Cantor Fitzgerald reaffirmed a “buy” rating and set a $490.00 price target on shares of Intuitive Surgical in a research report on Friday, January 26th. Piper Jaffray Companies reaffirmed a “hold” rating on shares of Intuitive Surgical in a research report on Friday, January 26th. Finally, Canaccord Genuity reaffirmed a “hold” rating and set a $410.00 price target (up from $380.00) on shares of Intuitive Surgical in a research report on Friday, January 26th. They noted that the move was a valuation call. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus price target of $415.21.
Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, January 25th. The medical equipment provider reported $2.54 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.27 by $0.27. Intuitive Surgical had a return on equity of 19.93% and a net margin of 21.09%. The business had revenue of $892.40 million during the quarter, compared to the consensus estimate of $866.54 million. During the same period last year, the business posted $2.03 earnings per share. The business’s revenue for the quarter was up 17.9% on a year-over-year basis. equities analysts forecast that Intuitive Surgical will post 7.85 earnings per share for the current fiscal year.
In other Intuitive Surgical news, Director Mark J. Rubash sold 1,000 shares of the firm’s stock in a transaction on Monday, March 5th. The stock was sold at an average price of $420.01, for a total value of $420,010.00. Following the completion of the sale, the director now directly owns 4,453 shares of the company’s stock, valued at $1,870,304.53. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, COO Salvatore Brogna sold 7,934 shares of the firm’s stock in a transaction on Thursday, March 1st. The stock was sold at an average price of $421.37, for a total value of $3,343,149.58. Following the completion of the sale, the chief operating officer now directly owns 6,159 shares of the company’s stock, valued at $2,595,217.83. The disclosure for this sale can be found here. Insiders sold 102,770 shares of company stock valued at $43,410,836 over the last three months. Company insiders own 2.20% of the company’s stock.
About Intuitive Surgical
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.